Update on the iPS Cell Stock at the CiRA Foundation
The iPS Cell Stock Project has expanded its Japanese population coverage to 60% by using 27 cell stocks. These stocks were prepared from donors who are homozygous for human leukocyte antigens (HLA) A, B, and DR, increasing the likelihood of donor-patient matching.